Clinical Trial

INfluenza VaccInation To Mitigate typE 1 Diabetes

Study acronym: INVITED
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 22, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In a multicenter, prospective, randomized, controlled clinical trial to compare influenza vaccination and placebo in sustaining β cell function in early type 1 diabetes mellitus.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-10-15; most recent amendment 2025-05-20.
Status change: Not Yet Recruiting → Recruiting 2022-12-14
Trial Details
NCT Number NCT05585983
Lead Sponsor Aarhus University Hospital
Conditions Diabetes Mellitus, Type 1
Enrollment 100 participants
Start Date 2022-12-14
Primary Completion 2026-05-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-22